Abstract
Keloids are fibroproliferative skin disorders caused by the improper healing of wounded skin. A growing body of evidence suggests the involvement of N6-Methyladenosine (m6A) modification in various bioprocesses; however, its role in keloid formation has not yet been investigated. The aim of this study was to determine the effect of the m6A regulator zinc finger CCCH domain containing protein 13 (ZC3H13) on the pathogenesis of keloid formation. ZC3H13 and homeodomain-interacting protein kinase 2 (HIPK2) expression was evaluated in healthy skin and keloid tissues, as well as in human dermal fibroblasts and human keloid fibroblasts (HKF), using qRT-PCR and western blotting. The effects of ZC3H13 overexpression and knockdown on the cell function of HKFs were assessed using CCK8, transwell, and flow cytometry. Furthermore, the influence of ZC3H13 on HIPK2 m6A modification was assessed using MeRIP-qPCR and mRNA stability assays. Both ZC3H13 expression and m6A RNA methylation were upregulated in keloid tissues and HKFs. Silencing of ZC3H13 inhibited proliferation and migration, while enhancing apoptosis in HKFs, whereas overexpression had the opposite effect. Furthermore, HIPK2 levels were high in keloid tissues and HKFs, and a positive correlation was observed between ZC3H13 and HIPK2. In HKFs, ZC3H13 overexpression elevated the m6A levels of HIPK2 mRNA and reduced the rate of HIPK2 mRNA degradation. Mechanically, ZC3H13-induced m6A modifications significantly improved HIPK2 mRNA stability. Collectively, ZC3H13 accelerated keloid formation by mediating the m6A modification of HIPK2 mRNA and maintaining its stability.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
The data used to support the findings of this study are included within the article.
References
Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43(Suppl 1):S3–S18. https://doi.org/10.1097/DSS.0000000000000819
Cao G, Li HB, Yin Z, Flavell RA (2016) Recent advances in dynamic m6A RNA modification. Open Biol 6(4):160003. https://doi.org/10.1098/rsob.160003
Feng Y, Zhou L, Sun X, Li Q (2017) Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies. Oncotarget 8(12):20452–20461. https://doi.org/10.18632/oncotarget.14723
Garufi A, Pistritto G, D’Orazi G (2023) HIPK2 as a Novel Regulator of Fibrosis. Cancers (Basel) 15(4). https://doi.org/10.3390/cancers15041059
Ghazawi FM, Zargham R, Gilardino MS et al (2018) Insights into the pathophysiology of hypertrophic scars and keloids: how do they differ? Adv Skin Wound Care 31(1):582–595. https://doi.org/10.1097/01.ASW.0000527576.27489.0f
Gong PJ, Shao YC, Yang Y et al (2020) Analysis of N6-Methyladenosine methyltransferase reveals METTL14 and ZC3H13 as Tumor suppressor genes in breast Cancer. Front Oncol 10:578963. https://doi.org/10.3389/fonc.2020.578963
Guo T, Duan H, Chen J et al (2021) N6-Methyladenosine writer gene ZC3H13 predicts Immune phenotype and Therapeutic Opportunities in kidney renal clear cell carcinoma. Front Oncol 11:718644. https://doi.org/10.3389/fonc.2021.718644
He L, Li H, Wu A et al (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18(1):176. https://doi.org/10.1186/s12943-019-1109-9
Hou J, Shan H, Zhang Y et al (2020) M(6)a RNA methylation regulators have prognostic value in papillary thyroid carcinoma. Am J Otolaryngol 41(4):102547. https://doi.org/10.1016/j.amjoto.2020.102547
Kuwahara H, Tosa M, Egawa S et al (2016) Examination of epithelial mesenchymal transition in keloid tissues and possibility of keloid therapy target. Plast Reconstr Surg Glob Open 4(11):e1138. https://doi.org/10.1097/GOX.0000000000001138
Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S (2020) The keloid disorder: heterogeneity, histopathology, Mechanisms and Models. Front Cell Dev Biol 8:360. https://doi.org/10.3389/fcell.2020.00360
Lin CX, Chen ZJ, Peng QL et al (2022) The m(6)A-methylated mRNA pattern and the activation of the wnt signaling pathway under the hyper-m(6)A-modifying condition in the keloid. Front Cell Dev Biol 10:947337. https://doi.org/10.3389/fcell.2022.947337
Nyika DT, Khumalo NP, Bayat A (2022) Genetics and Epigenetics of Keloids. Adv Wound Care (New Rochelle) 11(4):192–201. https://doi.org/10.1089/wound.2021.0094
Ouna BA, Stewart M, Helbig C, Clayton C (2012) The Trypanosoma brucei CCCH zinc finger proteins ZC3H12 and ZC3H13. Mol Biochem Parasitol 183(2):184–188. https://doi.org/10.1016/j.molbiopara.2012.02.006
Ren S, Ji Y, Wang M et al (2023) The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1. Ann Transl Med 11(1):15. https://doi.org/10.21037/atm-22-6021
Stevenson AW, Deng Z, Allahham A et al (2021) The epigenetics of keloids. Exp Dermatol 30(8):1099–1114. https://doi.org/10.1111/exd.14414
Su S, Li S, Deng T et al (2022) Cryo-EM structures of human m(6)a writer complexes. Cell Res 32(11):982–994. https://doi.org/10.1038/s41422-022-00725-8
Wang ZC, Zhao WY, Cao Y et al (2020) The roles of inflammation in keloid and hypertrophic scars. Front Immunol 11:603187. https://doi.org/10.3389/fimmu.2020.603187
Wang Q, Xie H, Peng H et al (2021) ZC3H13 Inhibits the Progression of Hepatocellular Carcinoma through m(6)A-PKM2-Mediated Glycolysis and Enhances Chemosensitivity. J Oncol 2021: 1328444. https://doi.org/10.1155/2021/1328444
Wen J, Lv R, Ma H et al (2018) Zc3h13 regulates nuclear RNA m(6)a methylation and mouse embryonic stem cell Self-Renewal. Mol Cell 69(6):1028–1038e1026. https://doi.org/10.1016/j.molcel.2018.02.015
Wu R, Jiang D, Wang Y, Wang X (2016) N (6)-Methyladenosine (m(6)A) methylation in mRNA with a dynamic and reversible epigenetic modification. Mol Biotechnol 58(7):450–459. https://doi.org/10.1007/s12033-016-9947-9
Wu S, Liu S, Cao Y et al (2022) Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma. Aging 14(5):2304–2319. https://doi.org/10.18632/aging.203939
Xie R, Chen W, Lv Y et al (2023) Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation. J Formos Med Assoc. https://doi.org/10.1016/j.jfma.2022.12.019
Yang Y, Hsu PJ, Chen YS, Yang YG (2018) Dynamic transcriptomic m(6)a decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res 28(6):616–624. https://doi.org/10.1038/s41422-018-0040-8
Yang R, Wang X, Zheng W et al (2023) Bioinformatics analysis and verification of m6A related genes based on the construction of keloid diagnostic model. Int Wound J. https://doi.org/10.1111/iwj.14144
Yuan FL, Sun ZL, Feng Y et al (2019) Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids. J Cell Physiol 234(12):21662–21669. https://doi.org/10.1002/jcp.28830
Zhao YX, Zhang GY, Wang AY et al (2017) Role of Homeodomain-Interacting protein kinase 2 in the pathogenesis of tissue fibrosis in keloid-derived keratinocytes. Ann Plast Surg 79(6):546–551. https://doi.org/10.1097/SAP.0000000000001243
Zhu D, Zhou J, Zhao J et al (2019) ZC3H13 suppresses colorectal cancer proliferation and invasion via inactivating Ras-ERK signaling. J Cell Physiol 234(6):8899–8907. https://doi.org/10.1002/jcp.27551
Acknowledgements
None.
Funding
None.
Author information
Authors and Affiliations
Contributions
MNF and YJC designed this study, performed the experiments and data analysis, as well as wrote this manuscript. XS reviewed and revised the manuscript. All authors approved this article.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Conflict of interest
The authors declare that there were no conflicts of interest.
Ethics Approval
The Ethics Committee of Huangshi Central Hospital (Huangshi, China) approved this study. Clinical tissues specimen processing was accomplished in accordance with the ethical principles of the Declaration of Helsinki. All patients completed an informed consent form.
Consent to Participate
All patients signed a written informed consent.
Consent for publication
All authors have provided their consent for the publication of this work.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fu, M., Chen, Y. & Shi, X. ZC3H13 Accelerates Keloid Formation by Mediating N6-methyladenosine Modification of HIPK2. Biochem Genet (2023). https://doi.org/10.1007/s10528-023-10514-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10528-023-10514-6